Literature DB >> 34464251

PEG-coated patch parenchymal closure technique and initial outcomes during minimally invasive partial nephrectomy.

Ryan McLarty1, Benjamin Beech1, Jan K Rudzinski1, Blair St Martin1, Howard Evans1.   

Abstract

INTRODUCTION: The Hemopatch® is a novel polyethylene glycol-coated (PEG-coated) collagen patch that acts as a topical hemostatic agent. It has been applied to a variety of surgical techniques. Here, we present our series and technique using a PEG-coated patch for minimally invasive partial nephrectomy (MIPN).
METHODS: We conducted a retrospective chart review of all patients undergoing MIPN by a single surgeon at a tertiary Canadian medical center between July and December 2018. We included patients if a PEG-coated patch was used to close the renal parenchymal defect. We also describe in detail our technique for laparoscopic patch deployment.
RESULTS: A total of 17 patients met inclusion criteria, of whom 12 were male. Mean age was 63 years old. Median size of renal mass was 2.85 cm in largest dimension and median RENAL score was 6. Hilar clamping was carried out in 12 (70.9%) cases, with an average warm ischemic time of 16.1 minutes. The remainder of cases were performed off-clamp. Median estimated blood loss was 238 mL and the mean change in hemoglobin on postoperative day 1 compared to preoperatively was 21.2 g/L. The average length of stay was 1.76 days. No patient required blood transfusion or underwent angioembolization or re-operation for bleeding within 90 days. There were no Clavien-Dindo grade 3 or greater complications.
CONCLUSIONS: A PEG-coated patch can be used safely and effectively in lieu of traditional two-layer renorrhaphy with acceptable outcomes. Larger, prospective series are required to ascertain its true value and cost-effectiveness.

Entities:  

Year:  2021        PMID: 34464251      PMCID: PMC8937597          DOI: 10.5489/cuaj.7286

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  13 in total

Review 1.  Clinical effectiveness and versatility of a sealing hemostatic patch (HEMOPATCH) in multiple surgical specialties.

Authors:  Kevin M Lewis; Shelly Ikeme; Tolu Olubunmi; Carl Erik Kuntze
Journal:  Expert Rev Med Devices       Date:  2018-04-26       Impact factor: 3.166

Review 2.  Management of the Small Renal Mass: a 2020 Update.

Authors:  Rand N Wilcox Vanden Berg; Spyridon P Basourakos; Samuel LaRussa; Timothy D McClure
Journal:  Curr Oncol Rep       Date:  2020-06-09       Impact factor: 5.075

3.  Canadian Update on Surgical Procedures (CUSP) Urology Group consensus for intraoperative hemostasis during minimally invasive partial nephrectomy.

Authors:  Douglas C Cheung; Christopher J D Wallis; Simon Possee; Camilla Tajzler; Maurice Anidjar; Keith Barrett; Tom Deklaj; Darrel E Drachenberg; Howard Evans; Christopher French; Geoffrey Gotto; Jason Izard; Umesh Jain; Jun Kawakami; Girish S Kulkarni; Jason Lee; Jeffrey McCracken; Thomas McGregor; Patrick O Richard; Neal E Rowe; Robert Sabbagh; Blair St Martin; Stephanie Tatzel; Naji Touma; Hugues Widmer; Joshua Wiesenthal; Brian Yang; Kevin C Zorn; Anil Kapoor; Antonio Finelli; Raj Satkunasivam
Journal:  Can Urol Assoc J       Date:  2020-06-09       Impact factor: 1.862

4.  Initial experiences with the Hemopatch® as a hemostatic agent in zero-ischemia partial nephrectomy.

Authors:  F Imkamp; Y Tolkach; M Wolters; S Jutzi; M Kramer; T Herrmann
Journal:  World J Urol       Date:  2014-09-20       Impact factor: 4.226

5.  Use of haemostatic agents and glues during laparoscopic partial nephrectomy: a multi-institutional survey from the United States and Europe of 1347 cases.

Authors:  Alberto Breda; Sevan V Stepanian; John S Lam; Joseph C Liao; Inderbir S Gill; Jose R Colombo; Giorgio Guazzoni; Michael D Stifelman; Kent T Perry; Antonio Celia; Guglielmo Breda; Paolo Fornara; Stephen V Jackman; Antonio Rosales; Juan Palou; Michael Grasso; Vincenzo Pansadoro; Vincenzo Disanto; Francesco Porpiglia; Claudio Milani; Claude C Abbou; Richard Gaston; Gunter Janetschek; Naeem A Soomro; Jean J De la Rosette; Pilar M Laguna; Peter G Schulam
Journal:  Eur Urol       Date:  2007-02-22       Impact factor: 20.096

6.  The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth.

Authors:  Alexander Kutikov; Robert G Uzzo
Journal:  J Urol       Date:  2009-07-17       Impact factor: 7.450

7.  A prospective, randomized, pilot trial of a polyethylene glycol (PEG)-coated collagen patch (Hemopatch®) for intraoperative hemostasis during deceased donor renal transplant.

Authors:  Anil Kapoor; Emily Chu Lee Wong; Gaurav Vasisth; Yanbo Guo; Fadil Hassan; Camilla Tajzler; Simreet Hansra; Kevin Piercey; Shahid Lambe
Journal:  Can Urol Assoc J       Date:  2019-06-17       Impact factor: 1.862

8.  Trends in Utilization of Robotic and Open Partial Nephrectomy for Management of cT1 Renal Masses.

Authors:  Mahmoud Alameddine; Tulay Koru-Sengul; Kevin J Moore; Feng Miao; Luís Felipe Sávio; Bruno Nahar; Nachiketh Soodana Prakash; Vivek Venkatramani; Joshua S Jue; Sanoj Punnen; Dipen J Parekh; Chad R Ritch; Mark L Gonzalgo
Journal:  Eur Urol Focus       Date:  2018-01-08

9.  Hemopatch® as a Hemostatic Agent is Safe in Partial Nephrectomy: A Large, Single-Surgeon Retrospective Evaluation.

Authors:  Marie C Hupe; Maximilian Büttner; Pouriya Faraj Tabrizi; Axel S Merseburger; Markus A Kuczyk; Florian Imkamp
Journal:  Adv Ther       Date:  2020-12-04       Impact factor: 3.845

Review 10.  Control of bleeding in surgical procedures: critical appraisal of HEMOPATCH (Sealing Hemostat).

Authors:  Kevin Michael Lewis; Carl Erik Kuntze; Heinz Gulle
Journal:  Med Devices (Auckl)       Date:  2015-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.